Brief: Toleranzia Reports Positive Outcome From Advisory Meeting With German Medicines Agency

Toleranzia AB

18/03/2024 07:33

March 18 (Reuters) - Toleranzia AB  TOLE.ST :
    * TOLERANZIA REPORTS POSITIVE OUTCOME FROM ADVISORY MEETING
WITH
THE GERMAN MEDICINES AGENCY FOR THE TOL2 DEVELOPMENT PROGRAM
    * WE ARE IN AN INTENSIVE PHASE OF FINALIZING CLINICAL TRIAL
APPLICATION TO ENSURE STUDY START IN SECOND HALF OF 2024

Source text for Eikon:  ID:nMFN3s2m5f 
Further company coverage:  TOLE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))